Partnership
Business model
- Pipeline
-
Partnership

As a platform technology, CRISPR-Cas3 is expected to have applications not only in medicine, but also in a wide range of industrial fields.
C4U collaborates with and licenses the technology to a variety of companies around the world.
- Partner
- Contents
- Details
License
-
-
TAUNS Laboratories, Inc.
- Development and marketing of diagnostic products utilizing CRISPR-Cas3 technology
-
TAUNS Laboratories, Inc.
-
-
iPS Portal, Inc
- Genetic modification contract services utilizing CRISPR-Cas3 technology
-
iPS Portal, Inc
-
-
NIPPON GENE CO., LTD.
- Manufacture and sell reagents utilizing CRISPR-Cas3 technology
-
NIPPON GENE CO., LTD.
-
-
Rege Nephro Co., Ltd.
- Manufacture and sell cells induced to differentiate from PKD1 gene knockout induced pluripotent stem cells (iPS cells)
-
Rege Nephro Co., Ltd.
-
-
CLEA Japan, Inc.
- Production and marketing of severely immunodeficient rats using CRISPR-Cas3 technology
-
CLEA Japan, Inc.
Partnership
-
-
Inplanta Innovations, Inc.
- Application of CRISPR-Cas3 technology in the plant field
-
Inplanta Innovations, Inc.
-
-
Euglena Co.,Ltd.
- Microalgae Genome Editing
-
Euglena Co.,Ltd.